5,6,7,8-Tetrahydro-pyrazolo[1,5-a]azepin-4-one, 98%, 250mg

tert-butyl 2-methyl-3-{[3-(propan-2-yloxy)propyl]amino}propanoate, 95.0%, 10g

Ethyl 4-acetyl-5-methylisoxazole-3-carboxylate, 95.0%, 10g

Pent-3-yn-2-one, 98%, 1g

1-(5-ETHYLPYRIMIDIN-2-YL)PIPERIDIN-4-YL METHANESULFONATE, 90.0%, 2g

(S)-tert-Butyl 1-(4-chlorobenzyl)pyrrolidin-3-ylcarbamate, 95.0%, 1g

(3aS,4R,6S,7R,7aR)-4-(Hydroxymethyl)-6-(4-methoxyphenoxy)-2,2-dimethyltetrahydro-4H-[1,3]dioxolo[4,5-c]pyran-7-ol, 97%, 250mg

2-Oxa-5-azabicyclo[2.2.1]heptan-3-one hydrochloride, 95.0%, 250mg

2,2-Dimethyl-1,3-dioxacyclohept-5-ene>98.0%(GC)5g

(4s)-6-(Propan-2-yl)-3,4-dihydro-2h-1-benzopyran-4-amine hydrochloride, 95%, 250mg

1-(diazyn-1-ium-1-yl)-16-oxo-16-(2,3,4,5,6-pentafluorophenoxy)-4,7,10,13-tetraoxa-1-azahexadecan-1-ide, 95%, 1g

Maprotiline Hydrochloride, >98.0%(HPLC)(T), 5g

(S)-2-((tert-Butoxycarbonyl)amino)-2-(2-methoxyphenyl)acetic acid, 95.0%, 1g